Report title: Japan pharma: FDA rejects Eisai's request for patent extension
from EIU Country Analysis
253 word report published Jul 03, 2009

Price $34.00 available for immediate download
Report Overview
 
Search Inside
 
About EIU Country Analysis

FROM DIALOG NEWSEDGE [Nikkei English News (Japan)] Eisai Co. (####.TO) said Friday the U.S. Food and Drug Administration didn't approve pediatric exclusivity status for its best-selling drug, Aricept, eliminating the possibility of a...

Source: Healthcare Industry Briefing
Geography / Regions: Japan
Industry: Healthcare, Pharma & biotech
Free Sample: Click Here to Download
Format:
HTML HTML


Enter the keyword(s) which you would like to search for within this document and click "Search"  


Price: $34.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.